NCT04097158View on ClinicalTrials.gov

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Amyotrophic Lateral Sclerosis
Interventions
OTHER

Sample Collection

The investigators will be collecting blood, urine, and spinal fluid samples.

Trial Locations (1)

92354

RECRUITING

Loma Linda University, Loma Linda

All Listed Sponsors
collaborator

Temple University

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

University of Southern California

OTHER

collaborator

Northwestern University

OTHER

lead

Loma Linda University

OTHER